scispace - formally typeset
Y

Yali Jia

Researcher at Oregon Health & Science University

Publications -  240
Citations -  15683

Yali Jia is an academic researcher from Oregon Health & Science University. The author has contributed to research in topics: Optical coherence tomography & Glaucoma. The author has an hindex of 49, co-authored 236 publications receiving 13061 citations. Previous affiliations of Yali Jia include University of Washington.

Papers
More filters
Journal ArticleDOI

Visualization of 3 Distinct Retinal Plexuses by Projection-Resolved Optical Coherence Tomography Angiography in Diabetic Retinopathy.

TL;DR: By presenting 3 retinal vascular plexuses distinctly, PR-OCTA reveals capillary abnormalities in deeper layers with clarity and may distinguish DR from healthy eyes and severe DR from mild DR with greater accuracy compared with conventional OCTA.
Journal ArticleDOI

Hepatocellular carcinoma‐associated mesenchymal stem cells promote hepatocarcinoma progression: Role of the S100A4‐miR155‐SOCS1‐MMP9 axis

TL;DR: S100A4 secreted from LC‐MSCs promotes the expression of miR‐155, which mediates the down‐regulation of suppressor of cytokine signaling 1, leading to the subsequent activation of STAT3 signaling, which results in increased tumor invasiveness.
Journal ArticleDOI

Detection of nonexudative choroidal neovascularization in age-related macular degeneration with optical coherence tomography angiography.

TL;DR: Optical coherence tomographic angiography can detect the presence of nonexudative CNV, lesions difficult to identify with fluorescein angiographer and OCT, which is needed to understand the significance and natural history of these lesions.
Journal ArticleDOI

MicroRNA-125b attenuates epithelial-mesenchymal transitions and targets stem-like liver cancer cells through small mothers against decapentaplegic 2 and 4.

TL;DR: Mechanistically, the data revealed that miR‐125b suppressed EMT and EMT‐associated traits of HCC cells by targeting small mothers against decapentaplegic (SMAD2 and 4.2) and exerts inhibitory effects on EMT/EMT-associated traits in HCC by SMAD2/4.2, which suggest a potential therapeutic treatment of miR•125b for liver cancer.
Journal ArticleDOI

Optical coherence tomography angiography of time course of choroidal neovascularization in response to anti-angiogenic treatment

TL;DR: Frequent OCT angiography reveals a previously unknown pattern of rapid shutdown and reappearance of CNV channels within treatment cycles, which could be useful as leading indicators of C NV activity that could guide treatment timing.